Yan; Yinfa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yan; Yinfa.The latest application filed is for "compounds as bruton tyrosine kinase inhibitors, preparation methods and medical applications thereof".

Company Profile

0.9.17

Yan; Yinfa - Bedminster NJ
Yan; Yinfa - Bedminste NJ
Yan; Yinfa - Bedminister NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds As Bruton Tyrosine Kinase Inhibitors, Preparation Methods And Medical Applications Thereof App 20220169645 - Li; Puhui ; et al.	2022-06-02
Tyrosine Kinase 2 Inhibitors, Preparation Methods And Medicinal Uses Thereof App 20220009910 - Zhuang; Linghang ; et al.	2022-01-13
Benzimidazole Derivatives as Modulators of Retinoid-Related Orphan Receptor Gamma (RORy) and Pharmaceutical Uses Thereof App 20210171471 - Yan; Yinfa ; et al.	2021-06-10
Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors Grant 10,144,737 - Zhang , et al. De	2018-12-04
Substituted Ethynyl Heterobicyclic Compounds As Tyrosine Kinase Inhibitors App 20170114063 - Zhang; Minsheng ; et al.	2017-04-27
Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation App 20100168106 - Malamas; Michael Sotirios ; et al.	2010-07-01
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for .beta.-secretase modulation Grant 7,705,030 - Malamas , et al. April 27, 2	2010-04-27
Amino-5,5-diphenylimidazolone derivatives for the inhibition of .beta.-secretase Grant 7,700,602 - Malamas , et al. April 20, 2	2010-04-20
Heterocyclyl-3-sulfonylindazoles As 5-hydroxytryptamine-6 Ligands App 20090253711 - Bernotas; Ronald Charles ; et al.	2009-10-08
Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,576,087 - Bernotas , et al. August 18, 2	2009-08-18
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands Grant 7,560,470 - Bernotas , et al. July 14, 2	2009-07-14
Amino-5,5-diphenylimidazolone Derivatives For The Inhibition Of Beta-secretase App 20090093498 - Malamas; Michael S. ; et al.	2009-04-09
Amino-5,5-diphenylimidazolone derivatives for the inhibition of .beta.-secretase Grant 7,482,349 - Malamas , et al. January 27, 2	2009-01-27
AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION App 20080306091 - Malamas; Michael Sotirios ; et al.	2008-12-11
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for .beta.-secretase modulation Grant 7,417,047 - Malamas , et al. August 26, 2	2008-08-26
Indolylalkylpyridin-2-amines for the inhibition of beta-secretase App 20080076801 - Yan; Yinfa ; et al.	2008-03-27
Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands App 20080015201 - Bernotas; Ronald Charles ; et al.	2008-01-17
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands App 20070232618 - Bernotas; Ronald Charles ; et al.	2007-10-04
Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,259,165 - Bernotas , et al. August 21, 2	2007-08-21
2-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation App 20070191431 - Zhou; Ping ; et al.	2007-08-16
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands Grant 7,238,696 - Bernotas , et al. July 3, 2	2007-07-03
Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation App 20070027199 - Malamas; Michael Sotirios ; et al.	2007-02-01
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation App 20070004786 - Malamas; Michael Sotirios ; et al.	2007-01-04
Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase App 20050282825 - Malamas, Michael S. ; et al.	2005-12-22
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands App 20040167122 - Bernotas, Ronald Charles ; et al.	2004-08-26
Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands App 20040167030 - Bernotas, Ronald Charles ; et al.	2004-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.